09.12.2012 Views

Table of Contents - WOC 2012

Table of Contents - WOC 2012

Table of Contents - WOC 2012

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>WOC</strong><strong>2012</strong> Abstract Book<br />

PO-COR-30<br />

Ocular Manifestations in a Patient with Ectrodactyly-Ectodermal<br />

Dysplasia-Cleft Syndrome.<br />

Garza-Leon Manuel (1,2) , Morales-Ochoa Hortencia (3)<br />

1. Destellos de Luz non pr<strong>of</strong>it Fundation<br />

2. Instituto para Preservacion de la vision<br />

3. Instituto Mexicano del Seguro Social<br />

Purpose: To report the clinical characteristics in a case <strong>of</strong> ectodermal dysplasia,<br />

ectrodactyly and clefting syndrome (EEC).<br />

Method: Case report.<br />

Results: We present a case <strong>of</strong> female patients, who complains <strong>of</strong> decreased<br />

vision and photophobia <strong>of</strong> 6 years, ophthalmic evaluation shows absence <strong>of</strong><br />

the meibomian glands and madarosis. Corneal manifestations were bilateral<br />

central vascularized corneal scars. Skeletal anomalies were ectrodactyly<br />

and lobster-claw deformity <strong>of</strong> both hands; facial anomalies were scare in the<br />

superior lip secondary to the surgical repair <strong>of</strong> the cleft lip and palate. With<br />

the systemic findings a diagnosis <strong>of</strong> ectodermal dysplasia, ectrodactyly and<br />

clefting syndrome was made.<br />

Conclusion: It is important to make a full ophthalmic and systemic evaluation in<br />

all patients with corneal scars to rule out associated systemic diseases.<br />

Ectodermal dysplasia, ectrodactyly and clefting syndrome can produce corneal<br />

neovascularization and scar secondary to chronic alterations <strong>of</strong> the surface<br />

and adnexae produced by the obstructed tear ducts; secondary tear film lipid<br />

layer deficiency; and primary corneal epithelial defects, usually in the early<br />

adulthood.<br />

PO-COR-31<br />

Use <strong>of</strong> Systemic Interferon Alpha-2a for the Treatment <strong>of</strong> Severe Dry<br />

Eye Due to Hepatitis C Infection<br />

Gracia García Alicia (1) , Calvo Andrés Ramon (1) , Navarro Palop Catalina (1) ,<br />

Domenech Aracil Nuria (1) , Cervera Taulet Enrique (1)<br />

1. Hospital General Universitario Valencia<br />

Purpose: To report a case presentation that the clinical management <strong>of</strong> the dry<br />

eye improved with systemic interferon.<br />

Methods: To report a clinical case <strong>of</strong> a 64-year-old woman with severe dry eye<br />

syndrome associated with chronic hepatitis C. Subjective symptoms <strong>of</strong> ocular<br />

dryness, signs were scored (corneal fluorescein staining, tear film break-up<br />

time, standard Schirmer test) and best-corrected visual acuity (BCVA) was<br />

measured. Topical treatment was started with high density artificial tears,<br />

dexpantenol ophthalmic ointment and cloranfenicol. Six weeks after the ocular<br />

symptoms started, the patient received subcutaneous interferon ?-2a therapy<br />

(180 mcg/week) with ribavirin 1000 mg/day orally for the initial treatment <strong>of</strong><br />

patients with chronic hepatitis C.<br />

Results: The patient received interferon therapy during six months. She was<br />

examined one month before and one, three and six months after the beginning<br />

<strong>of</strong> the treatment. Three months later, the ulcer layer epithelized totally and all<br />

dry eye parameters improved. The BCVA increased from counting fingers to<br />

20/100.<br />

Conclusions: Systemic interferon alpha-2a treatment might be an effective<br />

therapeutic strategy in patients with severe dry eye syndrome due to hepatitis<br />

C infection. Its use could improve autoimmune and inflammatory factors that<br />

can predispose to conventional dry eye treatment failure.<br />

492<br />

PO-COR-32<br />

New Surgical Technique for Trimming Glaucoma Tubes in<br />

Complicated Cornea and Aphakic Eyes- The NECKLACE Technique<br />

Wang Jenn Chyuan (1)<br />

1. Singapore National Eye Centre<br />

Objective: To describe a new surgical technique which allows safe and efficient<br />

way to shorten and remove the intra-ocular portion <strong>of</strong> the glaucoma drainage<br />

tube in conditions <strong>of</strong> media opacity and previous complicated cataract surgery.<br />

Methods: Demonstration <strong>of</strong> surgical technique in a single case <strong>of</strong> pseudophakic<br />

eye with bullous keratopathy undergoing Descemet Stripping Endothelial<br />

Keratoplasty Surgery. A Ethicon CTC-6 needle is used to pierce through the<br />

distal end <strong>of</strong> the <strong>of</strong> silicone tube. The needle exists through the main wound.<br />

The other end <strong>of</strong> the suture is retrieved via the main wound using a Kelman<br />

forceps. Both ends <strong>of</strong> the suture provide countertraction when the tube is cut,<br />

using an intra-ocular scissors, to the desired length.<br />

Results: The cut end is withdrawn safely out <strong>of</strong> the eye together with the suture.<br />

Conclusion: This simple technique provides a simple, safe and efficient way to<br />

shorten the glaucoma drainage tube conditions <strong>of</strong> media opacity and previous<br />

complicated cataract surgery.<br />

PO-COR-33<br />

Intacs SK IntraCorneal Ring Segment in the Management <strong>of</strong><br />

Keratoconus<br />

Khan Mohammad Irfan (1) , Injarie Anas (1) , Muhtaseb Mohammed (1)<br />

1. Singleton Hospital Abertawe Bro Morgannwg University NHS Trust<br />

Purpose: To report the safety and efficacy <strong>of</strong> Intacs SK in the management <strong>of</strong><br />

keratoconus.<br />

Methods: Retrospective non-randomized study <strong>of</strong> patients who had Intacs SK<br />

implanted manually for moderate to severe keratoconus and contact lens<br />

intolerance or ineffectiveness. Patients were seen at 0.5, 1, 3, 6, 9 and 12<br />

months post operatively. Outcome measures included uncorrected (UCVA)<br />

and best corrected (BCVA) visual acuity, refraction, corneal topography and<br />

slit lamp examination.<br />

Results: 31 eyes <strong>of</strong> 29 patients were evaluated. The mean UCVA was<br />

significantly better at 12 months postoperatively than preoperatively (0.88<br />

LogMAR versus 1.4 LogMAR) (P=0.001), as was the mean BCVA (0.29<br />

LogMAR versus 0.44 LogMAR) (P=0.04). The mean keratometry readings<br />

were reduced from 52.07 D (range 45.9 to 63.1D) to 46.15D (range 39.2 to<br />

52.9D) for K1 (P

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!